Loading ....
BHE12103012
Thrombin inhibitor activated by the glycosaminoglycans, heparin or dermatan sulfate. In the presence of the latter, HC-II becomes the predominant thrombin inhibitor in place of antithrombin III (AT-III). Also inhibits chymotrypsin, but in a glycosaminoglycan-independent manner. Peptides at the N-terminal of HC-II have chemotactic activity for both monocytes and neutrophils.
Contact us to order
Tel
+1 866.986.9598
Bioassay Technology Laboratory
view supplier detailsCredit card payments now incur a 3% fee.
